Adult Acute Monocytic Leukemia — Trials

Adult Acute Monocytic Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

70 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2
Recruiting: 0
Ph III recruiting: 0
Growth YoY: —
Industry share: 0%
Top sponsor: National Cancer Institute (NCI)
Termination share: 42.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (19)

clinicaltrialsPublishedShowing 1–8 of 8 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02030405	Ixazomib (MLN9708) in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia	terminated	Phase 2	4	Steven E. CoutreOTHER	1	Apr 5, 2019	clinicaltrials
NCT01342887	Cyclosporine, Pravastatin Sodium, Etoposide, and Mitoxantrone Hydrochloride in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia	terminated	Phase 1 / Phase 2	6	Fred Hutchinson Cancer CenterOTHER	1	Jul 2, 2017	clinicaltrials